AxoGen Nerve Cap— 510(k) K163446
Substantially EquivalentAxogen Corporation
FDA 510(k) clearance K163446 for AxoGen Nerve Cap, Substantially Equivalent on 2017-08-08. Applicant: Axogen Corporation.
Clearance details
- Applicant
- Axogen Corporation
- Product code
- Code JXI
- Advisory panel
- Neurology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Alachua, FL, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.